Divi's Laboratories
₹9,249.00Change from previous close: −0.46%Absolute change: −₹42.50
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ₹2.46T
- Enterprise value
- ₹2.42T
- P/E (trailing 12 months)
- 83.8
- Forward P/E
- 61.5
- Price/book
- 14.6
- Price/sales
- 21.9
- EV/EBITDA
- 61.1
- EV/revenue
- 21.6
Profitability and growth
- Gross margin
- 61.2%
- Operating margin
- 36.7%
- Net margin
- 26.0%
- Revenue growth (year over year)
- 27.8%
- Earnings growth (year over year)
- 65.7%
Financial health
- Total cash
- ₹32.33B
- Total debt
- ₹70M
- Debt/equity
- 0.00
Dividends
- Annual dividend per share
- ₹30.00
- Dividend yield
- 0.3%
- Payout ratio
- 27.2%
- Ex-dividend date
- July 24, 2026
Analysts and estimates
- Average price target
- ₹8,447.00
- Median price target
- ₹8,504.00
- High price target
- ₹11,700.00
- Low price target
- ₹6,000.00
- Analysts with a price target
- 29
- Consensus
- Hold
- Forward EPS
- ₹150.47
- EPS estimate, current year
- ₹123.24
Shares and trading
- Beta
- 0.25
- Average volume
- 502.28K
- Shares outstanding
- 265.47M
- Float
- 117.29M
- Institutional ownership
- 30.4%
- Insider ownership
- 52.0%